10.1136/bmj.a2097
Journal article
BMJ
20/11/2008
337
Clostridium difficile, Cross Infection, Enterocolitis, Pseudomembranous, Health Policy, Humans, Primary Health Care, Reimbursement, Incentive, State Medicine, United Kingdom